Non-canonical functions of SNAIL drive context-specific cancer progression

Mariel C Paul1,2, Christian Schneeweis1,2,3,4, Chiara Falcomatà1,2,4

  • 1Division of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Nature Communications
|March 7, 2023
PubMed

Insights

The transcription factor SNAIL has cancer-promoting roles independent of epithelial-mesenchymal transition (EMT). It bypasses senescence and cell cycle checkpoints, with effects varying by cancer type and genetic context.

Area of Science:

  • Oncology
  • Molecular Biology
  • Developmental Biology

Background:

  • SNAIL is a transcriptional regulator crucial for embryonic development and cancer.
  • Its known role as a master regulator of epithelial-to-mesenchymal transition (EMT) is thought to drive its effects in disease.
  • However, non-canonical functions in cancer remain to be fully elucidated.

Purpose of the Study:

  • To investigate the oncogenic functions of SNAIL independent of EMT.
  • To explore the context-dependent roles of SNAIL in various cancer types and genetic backgrounds.
  • To identify novel mechanisms by which SNAIL promotes tumorigenesis.

Main Methods:

  • Utilized genetic models to systematically interrogate SNAIL's effects in different oncogenic backgrounds and tissue types.
  • Analyzed SNAIL-driven oncogenesis in relation to E-cadherin expression and EMT markers.
  • Investigated SNAIL's impact on senescence and cell cycle regulation, focusing on the p16INK4A and Retinoblastoma (RB) pathways.

Main Results:

  • SNAIL exhibited context-dependent phenotypes, showing protective effects in some cancers (e.g., KRAS/WNT-driven intestinal) but accelerating tumorigenesis in others (e.g., KRAS-induced pancreatic).
  • Oncogenesis driven by SNAIL was not associated with E-cadherin downregulation or overt EMT.
  • SNAIL promoted cell cycle progression by inactivating the RB-restriction checkpoint independently of p16INK4A, leading to bypass of senescence.

Conclusions:

  • Identified novel, EMT-independent oncogenic functions of SNAIL in cancer.
  • Demonstrated that SNAIL's role in cancer is complex and highly dependent on the specific genetic and tissue context.
  • Uncovered a mechanism involving RB-restriction checkpoint inactivation for SNAIL-driven oncogenesis, distinct from its canonical EMT role.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K